FB-401

BIOLOGICAL2 trials

Sponsors

Forte Biosciences, Inc.

Conditions

Atopic Dermatitis

Phase 2

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

CompletedNCT04504279

Forte Biosciences, Inc.Atopic Dermatitis

Start: 2020-10-13End: 2021-08-19Updated: 2021-09-16

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

TerminatedNCT04936113

Forte Biosciences, Inc.Atopic Dermatitis

Start: 2021-06-02End: 2021-09-30Updated: 2021-10-28